Table 2.
Univariate Cox regression analyses of clinicopathologic factors in the prognosis of gastric cancer
| Factor | Univariate analyses | ||
|---|---|---|---|
|
| |||
| HR | 95% CI | P value | |
| Gender (Male vs. Female) | 1.14 | 0.64-1.59 | 0.771 |
| Age (<50 vs. ≥50) | 1.58 | 0.86-2.17 | 0.423 |
| Tumor size (<5 vs. ≥5) | 0.75 | 0.30-1.48 | 0.534 |
| Tumor location (Distal/middle vs. Proximal) | 1.43 | 0.81-1.90 | 0.361 |
| Differentiation (Well/moderate vs. Poor) | 2.25 | 0.97-3.74 | 0.085 |
| Borrmann type (I/II vs. III/IV) | 0.69 | 0.32-1.35 | 0.912 |
| CEA status (Negative vs. Positive) | 1.07 | 0.64-1.61 | 0.783 |
| Invasive depth (T1/T2 vs. T3/T4) | 1.34 | 0.65-1.88 | 0.302 |
| Distant metastasis (Negative vs. Positive) | 4.73 | 2.49-7.53 | <0.001* |
| TNM stage (I/II vs. III/IV) | 4.08 | 2.11-6.62 | <0.001* |
| Lymph node metastasis (Negative vs. Positive) | 2.15 | 1.23-4.09 | 0.016* |
| Circ_0026344 level (low vs. high) | 2.67 | 1.45-4.83 | 0.002* |
HR, hazard ratio; 95% CI, 95% confidence interval.
*
P<0.05.